Kezdőlap › Mellrák › Washington › Seattle
Mellrák klinikai vizsgálatok: Seattle, WA
39 Mellrák vizsgálat keres résztvevőket Seattle és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Toborzás folyamatban1/2. fázis
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- és további 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Center, Seattle
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Research Center, Seattle
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Research Center, Seattle
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Toborzás folyamatban3. fázis
- Fred Hutchinson Cancer Center ( Site 0069), Seattle
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Toborzás folyamatban2. fázis
- Fred Hutchinson Cancer Center, Seattle
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Swedish Medical Center, Seattle
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Toborzás folyamatban3. fázis
- Clinical Trial Site, Seattle
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Toborzás folyamatban
- Fred Hutch Cancer Center, Seattle
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Toborzás folyamatban3. fázis
- Swedish Medical Center, Seattle
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
Toborzás folyamatban
- University of Washington, Seattle
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Toborzás folyamatban3. fázis
- Swedish Medical Center, Seattle
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Toborzás folyamatban3. fázis
- Virginia Mason Medical Center, Seattle
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- és további 1
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Research Center, Seattle
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Center, Seattle
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Toborzás folyamatban3. fázis
- Swedish Cancer Institute - Issaquah, Seattle
- Swedish Cancer Institute, Seattle
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Toborzás folyamatban3. fázis
- Virginia Mason Medical Center, Seattle
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- és további 5
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Fred Hutch Cancer Research, Seattle
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
Toborzás folyamatban2. fázis
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Toborzás folyamatban
- Swedish Cancer Institute, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Toborzás folyamatban1/2. fázis
- Swedish Cancer Institute, Seattle
E-Mindfulness Approaches for Living After Breast Cancer
Toborzás folyamatban3. fázis
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mérföldre
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Toborzás folyamatban1. fázis
- University Of Washington, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Toborzás folyamatban2. fázis
- University of Washington School of Medicine, Seattle
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
Toborzás folyamatban1/2. fázis
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Toborzás folyamatban3. fázis
- Fred Hutchinson Cancer Center, Seattle
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Toborzás folyamatban3. fázis
- Fred Hutchinson Cancer Center, Seattle
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Toborzás folyamatban3. fázis
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-First Hill, Seattle
- Saint Michael Cancer Center, Silverdale · 17 mérföldre
Quantitative MRI Assessment of Breast Cancer Therapy Response
Toborzás folyamatbanMegfigyeléses tanulmány
- University of Washington, Seattle
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Toborzás folyamatban2. fázis
- University of Washington, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Toborzás folyamatbanMegfigyeléses tanulmány
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Seattle
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Toborzás folyamatban3. fázis
- FHCC South Lake Union, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Toborzás folyamatbanMegfigyeléses tanulmány
- Swedish Cancer Institute, Seattle
- Seattle Cancer Care Alliance, Seattle
Mellrák vizsgálatok más városokban
- New York City, NY134 tanulmány
- Houston, TX126 tanulmány
- Boston, MA111 tanulmány
- Nashville, TN80 tanulmány
- Los Angeles, CA72 tanulmány
- Edison, NJ68 tanulmány
- St. Louis, MO64 tanulmány
- Durham, NC63 tanulmány
- Queens, NY63 tanulmány
- Chicago, IL58 tanulmány
- Philadelphia, PA56 tanulmány
- Dallas, TX55 tanulmány
Egyéb vizsgálatok: Seattle
- Nem kis sejtes tüdőrák53 tanulmány
- Rák (minden típus)49 tanulmány
- Prosztatarák42 tanulmány
- Akut mieloid leukémia40 tanulmány
- Áttétes rák39 tanulmány
- Kolorektális rák34 tanulmány
- Tüdőrák33 tanulmány
- Petefészekrák30 tanulmány
- Multiplex mielóma22 tanulmány
- Myelodysplasticus szindrómák21 tanulmány
- Akut limfoblasztos leukémia21 tanulmány
- Hólyagrák21 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 5.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.